CUAMC
China Universal Asset Management Company’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $844K | Buy |
17,346
+141
| +0.8% | +$6.86K | 0.08% | 187 |
|
|
2025
Q1 | $585K | Sell |
17,205
-893
| -5% | -$30.4K | 0.05% | 235 |
|
|
2024
Q4 | $712K | Buy |
18,098
+1,717
| +10% | +$67.6K | 0.07% | 208 |
|
|
2024
Q3 | $770K | Buy |
16,381
+6,405
| +64% | +$301K | 0.08% | 165 |
|
|
2024
Q2 | $539K | Sell |
9,976
-5,433
| -35% | -$293K | 0.08% | 140 |
|
|
2024
Q1 | $1.05M | Buy |
15,409
+6,216
| +68% | +$424K | 0.13% | 124 |
|
|
2023
Q4 | $575K | Buy |
9,193
+7,152
| +350% | +$448K | 0.11% | 136 |
|
|
2023
Q3 | $92.6K | Buy |
2,041
+1,007
| +97% | +$45.7K | 0.03% | 198 |
|
|
2023
Q2 | $58K | Sell |
1,034
-31
| -3% | -$1.74K | 0.02% | 181 |
|
|
2023
Q1 | $48.2K | Sell |
1,065
-2,533
| -70% | -$115K | 0.02% | 154 |
|
|
2022
Q4 | $146K | Sell |
3,598
-20,985
| -85% | -$853K | 0.06% | 109 |
|
|
2022
Q3 | $1.61M | Buy |
24,583
+23,250
| +1,744% | +$1.52M | 0.68% | 51 |
|
|
2022
Q2 | $81K | Hold |
1,333
| – | – | 0.03% | 77 |
|
|
2022
Q1 | $84K | Buy |
+1,333
| New | +$84K | 0.03% | 73 |
|